Voloridge Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,497
Closed -$741K 1362
2024
Q4
$741K Sell
20,497
-116,964
-85% -$4.23M ﹤0.01% 1072
2024
Q3
$4.29M Sell
137,461
-34,805
-20% -$1.09M 0.02% 813
2024
Q2
$4.61M Buy
+172,266
New +$4.61M 0.02% 775
2024
Q1
Sell
-149,150
Closed -$4.32M 1348
2023
Q4
$4.32M Buy
149,150
+46,647
+46% +$1.35M 0.02% 658
2023
Q3
$2.83M Buy
102,503
+71,744
+233% +$1.98M 0.01% 824
2023
Q2
$925K Buy
+30,759
New +$925K ﹤0.01% 1134
2021
Q4
Sell
-63,894
Closed -$1.7M 1836
2021
Q3
$1.7M Buy
+63,894
New +$1.7M 0.01% 1100
2021
Q2
Sell
-57,283
Closed -$1.5M 1780
2021
Q1
$1.5M Sell
57,283
-72,885
-56% -$1.91M 0.01% 908
2020
Q4
$3.28M Sell
130,168
-19,632
-13% -$494K 0.03% 574
2020
Q3
$3.12M Buy
149,800
+6,799
+5% +$142K 0.03% 576
2020
Q2
$3.4M Buy
143,001
+8,662
+6% +$206K 0.04% 458
2020
Q1
$2.42M Buy
134,339
+63,110
+89% +$1.14M 0.07% 304
2019
Q4
$1.69M Buy
71,229
+52,341
+277% +$1.24M 0.03% 527
2019
Q3
$519K Sell
18,888
-14,628
-44% -$402K 0.01% 800
2019
Q2
$1.11M Buy
33,516
+4,037
+14% +$134K 0.03% 439
2019
Q1
$1.03M Sell
29,479
-11,363
-28% -$398K 0.03% 462
2018
Q4
$1.36M Buy
+40,842
New +$1.36M 0.06% 240
2018
Q3
Sell
-33,753
Closed -$2.02M 454
2018
Q2
$2.02M Buy
+33,753
New +$2.02M 0.05% 273
2017
Q3
Sell
-29,412
Closed -$1.27M 523
2017
Q2
$1.27M Buy
+29,412
New +$1.27M 0.03% 306